[Economic evaluation of an extraordinary vaccination against tetanus in CSR (author's transl)]. 1982

V Janout, and G Walter, and E Svandová, and L Král

UI MeSH Term Description Entries
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

V Janout, and G Walter, and E Svandová, and L Král
May 1977, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
V Janout, and G Walter, and E Svandová, and L Král
March 1981, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
V Janout, and G Walter, and E Svandová, and L Král
March 1976, Ceskoslovenska gynekologie,
V Janout, and G Walter, and E Svandová, and L Král
August 1976, Ceskoslovenska psychiatrie,
V Janout, and G Walter, and E Svandová, and L Král
January 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
V Janout, and G Walter, and E Svandová, and L Král
January 1979, Annali Sclavo; rivista di microbiologia e di immunologia,
V Janout, and G Walter, and E Svandová, and L Král
July 1978, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
V Janout, and G Walter, and E Svandová, and L Král
January 1981, Annali Sclavo; rivista di microbiologia e di immunologia,
V Janout, and G Walter, and E Svandová, and L Král
April 1974, Wiener klinische Wochenschrift,
V Janout, and G Walter, and E Svandová, and L Král
January 1981, Bulletin de la Societe de pathologie exotique et de ses filiales,
Copied contents to your clipboard!